MoonLake Immunotherapeutics, (MLTX): Price and Financial Metrics


MoonLake Immunotherapeutics, (MLTX): $5.00

-0.13 (-2.53%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MLTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

MLTX Stock Price Chart Interactive Chart >

Price chart for MLTX

MLTX Price/Volume Stats

Current price $5.00 52-week high $15.19
Prev. close $5.13 52-week low $4.25
Day low $5.00 Volume 651
Day high $5.11 Avg. volume 120,455
50-day MA $5.71 Dividend yield N/A
200-day MA $8.84 Market Cap 74.03M

MoonLake Immunotherapeutics, (MLTX) Company Bio


MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.


MLTX Latest News Stream


Event/Time News Detail
Loading, please wait...

MLTX Latest Social Stream


Loading social stream, please wait...

View Full MLTX Social Stream

MLTX Price Returns

1-mo N/A
3-mo -54.95%
6-mo -49.44%
1-year -51.27%
3-year N/A
5-year N/A
YTD -49.44%
2021 -13.02%
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6489 seconds.